Valued at a market cap of $39.8 billion, Becton, Dickinson and Company (BDX) is a Franklin Lakes, New Jersey-based company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public.
Companies worth $10 billion or more are typically classified as “large-cap stocks,” and BDX fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the medical instruments & supplies industry. The company’s core strength lies in its immense operational scale and its deeply entrenched role in global healthcare delivery, manufacturing more than 34 billion medical devices annually. The company specializes in producing high-volume clinical consumables, such as safety-engineered needles, syringes, and specimen collection systems, which form the essential baseline infrastructure for hospitals worldwide.
